These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18708696)

  • 21. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
    Thevis M; Thomas A; Kohler M; Beuck S; Schänzer W
    J Mass Spectrom; 2009 Apr; 44(4):442-60. PubMed ID: 19373874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
    Guddat S; Solymos E; Orlovius A; Thomas A; Sigmund G; Geyer H; Thevis M; Schänzer W
    Drug Test Anal; 2011; 3(11-12):836-50. PubMed ID: 22135086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes.
    Kuuranne T; Leinonen A; Schänzer W; Kamber M; Kostiainen R; Thevis M
    Drug Metab Dispos; 2008 Mar; 36(3):571-81. PubMed ID: 18086831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing.
    Thevis M; Piper T; Horning S; Juchelka D; Schänzer W
    Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1904-12. PubMed ID: 23939956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of in vitro synthesised metabolites of 4,9,11-trien-3-one steroids by liquid chromatography mass spectrometry.
    Kuuranne T; Pystynen KH; Thevis M; Leinonen A; Schänzer W; Kostiainen R
    Eur J Mass Spectrom (Chichester); 2008; 14(3):181-9. PubMed ID: 18708698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f.
    Möller T; Wen HC; Naumann N; Krug O; Thevis M
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing.
    Guddat S; Fußhöller G; Beuck S; Thomas A; Geyer H; Rydevik A; Bondesson U; Hedeland M; Lagojda A; Schänzer W; Thevis M
    Anal Bioanal Chem; 2013 Oct; 405(25):8285-94. PubMed ID: 23877183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
    Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
    Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation.
    Thevis M; Volmer DA
    Eur J Mass Spectrom (Chichester); 2018 Feb; 24(1):145-156. PubMed ID: 29232975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective androgen receptor modulators: comparative excretion study of bicalutamide in bovine urine and faeces.
    Rojas D; Dervilly-Pinel G; Cesbron N; Penot M; Sydor A; Prévost S; Le Bizec B
    Drug Test Anal; 2017 Jul; 9(7):1017-1025. PubMed ID: 27726308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
    Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
    J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro metabolism study of a black market product containing SARM LGD-4033.
    Geldof L; Pozo OJ; Lootens L; Morthier W; Van Eenoo P; Deventer K
    Drug Test Anal; 2017 Feb; 9(2):168-178. PubMed ID: 26767942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample.
    Starcevic B; Ahrens BD; Butch AW
    Drug Test Anal; 2013 May; 5(5):377-9. PubMed ID: 23427117
    [No Abstract]   [Full Text] [Related]  

  • 37. In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent.
    Taoussi O; Bambagiotti G; Gameli PS; Daziani G; Tavoletta F; Tini A; Basile G; Lo Faro AF; Carlier J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.
    Thevis M; Geyer H; Thomas A; Schänzer W
    Drug Test Anal; 2011 May; 3(5):331-6. PubMed ID: 21538997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes.
    Cutler C; Viljanto M; Taylor P; Hincks P; Biddle S; Van Eenoo P
    Drug Test Anal; 2022 Feb; 14(2):349-370. PubMed ID: 34714606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.